Basic Information
| LncRNA/CircRNA Name | EPEL |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | tissues ,cell lines (U2OS, MG-63,SAOS-2) |
| Expression Pattern | up-regulated |
| Function Description | The results revealed that EPEL was upregulated in tumor tissues compared with adjacent tissues. |
| Pubmed ID | 30867743 |
| Year | 2019 |
| Title | EPEL promotes the migration and invasion of osteosarcoma cells by upregulating ROCK1. |
External Links
| Links for EPEL | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |